Login / Signup

Safety and Duration of Effect of 40-Unit PrabotulinumtoxinA-xvfs for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients: A Phase II, Multicenter, Randomized, Double-Blind, Active-Controlled Trial.

Steven FagienRui L AvelarSue Ellen CoxJohn H JosephJoely Kaufman-JanetteKeith A Marcus
Published in: Aesthetic surgery journal (2024)
Keyphrases
  • double blind
  • phase ii
  • placebo controlled
  • clinical trial
  • open label
  • phase iii
  • study protocol
  • early onset
  • combination therapy